Mon, March 2, 2020

David Nierengarten Initiated (BEAM) at Buy and Held Target at $32 on, Mar 2nd, 2020

David Nierengarten of Wedbush, Initiated "Beam Therapeutics Inc." (BEAM) at Buy and Held Target at $32 on, Mar 2nd, 2020.

David, nor any peers, have made any analyst calls on BEAM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30